Grifols
Generated by Meeveem AI
"Global leader in plasma-derived medicines transforming lives through science since 1909"
Sant Cugat del Vallès
•1000+ Employees
•Pharmaceuticals
About Grifols
Grifols develops plasma-derived medicines and diagnostics that enable millions of patients with chronic and rare diseases to lead more productive lives. Operating the world's largest network of plasma donation centres, the company transforms donated plasma into essential treatments for immunology, neurology, hepatology, hematology and infectious diseases across more than 110 countries. Founded in Barcelona in 1909, Grifols combines over a century of expertise in plasma science with ethical leadership and industry-leading quality standards. The company invests deeply in research to advance understanding of human health, developing both plasma and non-plasma therapies that address unmet medical needs for patients worldwide.
23800
Team Members
1909
Founded
Pharmaceuticals
Sector
Hybrid
Work Environment
Our Vision
A world where every patient has access to life-enhancing plasma therapies and diagnostic solutions, enabling healthier, more productive lives across all communities and advancing global health equity through scientific innovation.
Our Mission
At Grifols, our mission is to innovate and deliver differentiated biopharma therapeutics and unique diagnostic solutions globally and sustainably.